PDK1 signaling toward PLK1-MYC activation confers oncogenic transformation, tumor-initiating cell activation, and resistance to mTOR-targeted therapy

• Main Authors: Tan, J., Li, Z., Lee, P.L., Guan, P., Aau, M.Y., Lee, S.T., Feng, M., Lim, C.Z., Lee, E.Y.J., Wee, Z.N., Lim, Y.C., Karuturi, R.K.M., Yu, Q.
• 其他作者: GENOME INSTITUTE OF SINGAPORE
• 格式: Article
• 出版: 2014
• 在線閱讀: http://scholarbank.nus.edu.sg/handle/10635/115861
• 機構: National University of Singapore

10.1158/2159-8290.CD-12-0595